Biomea Fusion, Inc. (BMEA) Income Statement
BMEA 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsBMEA revenue and net income
BMEA growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
BMEA quarterly EPS vs estimates
Biomea Fusion beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 3, 2026 (estimate $-0.21).
BMEA income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $1.4M | $1.7M | $4.2M | $1.3M | $953,000 | $132,000 | — |
| Gross profit | −$1.4M | −$1.7M | −$4.2M | −$1.3M | −$953,000 | −$132,000 | — |
| Research & development | $62.0M | $118.1M | $102.5M | $62.7M | $28.0M | $3.7M | $1.1M |
| Sales, general & admin | $19.3M | $26.0M | $23.6M | $20.9M | $13.7M | $1.7M | $103,000 |
| Total operating expenses | $79.9M | $144.1M | $126.1M | $83.6M | $41.7M | $5.2M | $1.2M |
| Operating income | −$81.3M | −$144.1M | −$126.1M | −$83.6M | −$41.7M | −$5.3M | −$1.2M |
| Interest income | $1.9M | $5.6M | $8.9M | $1.8M | $100,000 | $3,000 | $3,000 |
| Interest expense | — | — | — | $1.8M | $100,000 | $0 | $0 |
| Income before taxes | −$61.8M | −$138.4M | −$117.3M | −$81.8M | −$41.6M | −$5.3M | −$1.2M |
| Income taxes | — | — | — | −$1.8M | −$349,000 | −$198,297 | $3,000 |
| Net income | −$61.8M | −$138.4M | −$117.3M | −$80.0M | −$41.2M | −$5.3M | −$1.2M |
| EBITDA | −$60.4M | −$136.7M | −$115.7M | −$82.9M | −$41.4M | −$5.2M | −$1.2M |
| EPS (diluted) | −$1.67 | −$3.84 | −$3.46 | −$2.79 | −$1.76 | −$0.20 | −$0.20 |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $1.2M | $0 | $0 | $0 | $6.1M | $0 |
| Cost of revenue | — | $46,000 | $47,000 | $400,000 | $500,000 | — | $0 | $400,000 | $400,000 | $420,000 | $1.1M | $1.1M |
| Gross profit | — | −$46,000 | −$47,000 | −$400,000 | −$500,000 | — | $1.2M | −$400,000 | −$400,000 | −$420,000 | $5.0M | −$1.1M |
| Research & development | $9.1M | $9.1M | $8.1M | $14.4M | $16.6M | $22.9M | $25.2M | $27.2M | $31.8M | $33.8M | $30.9M | $25.3M |
| Sales, general & admin | $3.6M | $3.7M | $3.6M | $4.2M | $4.7M | $6.8M | $4.8M | $6.8M | $7.5M | $7.7M | $6.5M | $5.8M |
| Total operating expenses | $12.8M | $12.7M | $11.7M | $20.8M | $20.8M | $29.7M | $30.1M | $34.0M | $38.9M | $41.1M | $37.3M | $31.1M |
| Operating income | −$12.8M | −$12.8M | −$11.7M | −$20.8M | −$21.3M | −$29.7M | −$30.1M | −$34.0M | −$38.9M | −$41.1M | −$37.3M | −$31.1M |
| Interest income | $319,000 | $430,000 | $3.5M | $4.4M | $536,000 | $450,000 | $772,000 | $1.3M | $1.6M | $2.0M | $2.4M | $2.7M |
| Interest expense | — | — | — | — | — | — | — | — | — | — | $980,000 | — |
| Income before taxes | −$8.3M | −$12.4M | $4.6M | −$16.4M | −$20.7M | −$29.3M | −$29.3M | −$32.8M | −$37.3M | −$39.1M | −$34.9M | −$28.4M |
| Income taxes | — | — | — | — | — | — | — | −$400,000 | — | $376,724 | $1.8M | −$419,000 |
| Net income | −$8.3M | −$12.4M | $4.6M | −$16.4M | −$20.7M | −$29.3M | −$29.3M | −$32.8M | −$37.3M | −$39.1M | −$34.9M | −$28.4M |
| EBITDA | −$8.3M | −$12.4M | $4.7M | −$18.2M | −$20.2M | −$28.8M | −$28.8M | −$32.4M | −$36.9M | −$38.6M | −$34.5M | −$28.0M |
| EPS (diluted) | −$0.12 | −$0.17 | −$0.12 | −$0.24 | −$0.51 | −$0.80 | −$0.81 | −$0.91 | −$1.03 | −$1.09 | −$0.98 | −$0.80 |
| Gross margin | — | — | — | — | — | — | 100.0% | — | — | — | 81.6% | — |
| Operating margin | — | — | — | — | — | — | −2,465.1% | — | — | — | −607.7% | — |
| Net margin | — | — | — | — | — | — | −2,401.8% | — | — | — | −568.0% | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in BMEA's financial statements (latest annual report filed March 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
BMEA financial results
Biomea Fusion reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of $61.8 million. Diluted earnings per share came to −$1.67.
See the BMEA stock overview for the latest quote and news, or the BMEA chart for price history and technical indicators.
BMEA income statement FAQ
Does Biomea Fusion have revenue?
Biomea Fusion reported no revenue for fiscal year 2025, which ended on December 31, 2025.
Is Biomea Fusion profitable?
No. Biomea Fusion reported a net loss of $61.8 million in fiscal 2025.
How much does Biomea Fusion spend on research and development?
Biomea Fusion spent $62.0 million on research and development in fiscal 2025.
What are Biomea Fusion's earnings per share?
Biomea Fusion earned $-1.67 per diluted share in fiscal 2025, compared with $-3.84 a year earlier.
When will Biomea Fusion report its next earnings?
Biomea Fusion is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes.
When does Biomea Fusion's fiscal year end?
Biomea Fusion's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 24, 2026.